Share chart Achieve Life Sciences, Inc.
Extended chart
Simple chart
About Achieve Life Sciences, Inc.
Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes cytisinicline for smoking cessation and nicotine addiction in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain that reduce the severity of nicotine withdrawal symptoms. It has license agreements with Sopharma AD and University of Bristol. Achieve Life Sciences, Inc. is based in Vancouver, Canada.Main settings
IPO date | 1995-10-13 |
---|---|
ISIN | US0044685008 |
Industry | Biotechnology |
Sector | Health Care |
Валюта | usd |
Валюта отчета | usd |
Сайт | link |
Change price per day: | -0.9177% (3.16) |
---|---|
Change price per week: | -0.2866% (3.14) |
Change price per month: | +31.55% (2.38) |
Change price per 3 month: | +3.33% (3.03) |
Change price per half year: | -30.27% (4.49) |
Change price per year: | -41.59% (5.36) |
Change price per 3 year: | -51.46% (6.45) |
Change price per 5 year: | +580.8% (0.4599) |
Change price per year to date: | -17.39% (3.79) |
Grade
Underestimation
Title | Value | Grade |
---|---|---|
P/S | 0 | 0 |
P/BV | 5.4 | 2 |
P/E | 0 | 0 |
Efficiency
Title | Value | Grade |
---|---|---|
ROA, % | -137.33 | 0 |
ROE, % | -409.51 | 0 |
ROIC, % | 0 | 0 |
Dividends
Title | Value | Grade |
---|---|---|
Dividend yield | 0 | 0 |
DSI | 0 | 0 |
Average dividend growth | 0 | 0 |
Debt
Title | Value | Grade |
---|---|---|
Debt/EBITDA | -0.2661 | 10 |
Debt/Ratio | 0.2578 | 10 |
Debt/Equity | 0.8486 | 9 |
Growth impulse
Title | Value | Grade |
---|---|---|
Yield Revenue, % | -74.81 | 0 |
Yield Ebitda, % | 158.06 | 10 |
Yield EPS, % | -76.96 | 0 |
Main owners
Institutions | Volume | Share, % |
---|---|---|
Shay Capital LLC | 725 000 | 2.12 |
Vanguard Group Inc | 605 710 | 1.77 |
Long Focus Capital Management, LLC | 248 099 | 0.72 |
Geode Capital Management, LLC | 184 925 | 0.54 |
LPL Financial LLC | 178 500 | 0.52 |
Raymond James & Associates, Inc. | 154 829 | 0.45 |
Northern Trust Corporation | 101 984 | 0.3 |
Walleye Capital LLC | 82 599 | 0.24 |
Wells Fargo & Company | 69 891 | 0.2 |
J. Goldman & Co., L.P. | 67 501 | 0.2 |
Similar companies
P/E & P/BV
Company management
Head | Job title | Payment | Year of birth |
---|---|---|---|
Dr. Richard A. B. Stewart | CEO & Executive Director | 663.75k | 1959 (66 years) |
Dr. Cindy Jacobs M.D., Ph.D. | President, Chief Medical Officer & Director | 652.74k | 1958 (67 years) |
Mr. Jerry Wan | Principal Accounting Officer | N/A | 1982 (43 years) |
Ms. Jaime Xinos | Executive Vice President of Commercial | N/A | |
Dr. Anthony Clarke Ph.D. | Chief Scientific Officer | 546k | 1956 (69 years) |
Mr. Thomas B. King M.B.A. | Executive Chairman | 1955 (70 years) |
About company
Address: Canada, Vancouver. BC VE H, 1040 West Georgia Street - Open in google maps, Open in yandex maps
Website: https://www.achievelifesciences.com
Website: https://www.achievelifesciences.com